Bausch + Lomb Corp will pay $1.75 billion to acquire a dry-eye drug from Swiss pharmaceutical giant Novartis, the Wall Street Journal reported on Friday.
(Reporting by Leroy Leo in Bengaluru; Editing by Anil D'Silva)
Bausch + Lomb to buy dry-eye drug from Novartis for $1.75 billion - WSJ
2023-06-30 19:22
Bausch + Lomb Corp will pay $1.75 billion to acquire a dry-eye drug from Swiss pharmaceutical giant Novartis,
You Might Like...
As worker actions continue nationwide, White House highlights how administration is helping unions
GM recalls nearly 900 vehicles with Takata air bag inflators, blames manufacturing problem
Climate protesters dragged from Shell shareholder meeting as they rush stage
Porsche's iconic 911 to be sole survivor of automaker's combustion models
RGI Announces Appointment of Patricia Fouqueray as Country Manager of KAPIA-RGI
Intel’s New Fab in Ireland Begins High-Volume Production of Intel 4 Technology
Titan Casket Announces David Dastmalchian as First Ever Celebrity Casket Ambassador
Poland to raise minimum wage twice in 2024, minister says